Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial - Sorbonne Université
Journal Articles Clinical Infectious Diseases Year : 2018

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

Alejandro Arenas-Pinto
  • Function : Author
Birgit Grund
  • Function : Author
Shweta Sharma
  • Function : Author
University of Minnesota Medical School
Esteban Martinez
  • Function : Author
Nathan Cummins
  • Function : Author
Julie Fox
  • Function : Author
NHS Foundation Trust [London]
Karin L Klingman
  • Function : Author
Dalibor Sedlacek
  • Function : Author
Simon Collins
  • Function : Author
Patricia M Flynn
  • Function : Author
William M Chasanov
  • Function : Author
Eynat Kedem
  • Function : Author
Christine Katlama
  • Function : Author
CHU Pitié-Salpêtrière [AP-HP]
Institut Pierre Louis d'Epidémiologie et de Santé Publique
Juan Sierra-Madero
  • Function : Author
Claudia Afonso
  • Function : Author
Pim Brouwers
  • Function : Author
David A Cooper
  • Function : Author

Domains

Human health and pathology

Gestionnaire HAL 3 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03793423

Submitted on : Saturday, October 1, 2022-10:22:36 AM

Last modification on : Thursday, November 7, 2024-2:21:17 PM

Consult the full text

Dates and versions

hal-03793423 , version 1 (01-10-2022)

Identifiers

Cite

Alejandro Arenas-Pinto, Birgit Grund, Shweta Sharma, Esteban Martinez, Nathan Cummins, et al.. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial. Clinical Infectious Diseases, 2018, 67 (3), pp.420--429. ⟨10.1093/cid/ciy051⟩. ⟨hal-03793423⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IPLESP SORBONNE-UNIVERSITE SU-MEDECINE
19 View
0 Download

Altmetric

Share

More